Natural Product (NP) Details
General Information of the NP (ID: NP3890) | |||||
---|---|---|---|---|---|
Name |
Yomogin
|
||||
Synonyms |
Yomogin; 10067-18-2; 2-Naphthaleneacetic acid, 1,2beta,3,4,4a,7-hexahydro-3alpha-hydroxy-4aalpha,8-dimethyl-alpha-methylene-7-oxo-, gamma-lactone; CHEMBL4547184; DTXSID50143436; 1,2beta,3,4,4a,7-hexahydro-3alpha-hydroxy-4aalpha,8-dimethyl-alpha-methylene-7-oxo-2-naphthaleneacetic acid gamma-lactone; Naphtho(2,3-b)furan-2,6(3H,4H)-dione, 3a,8a,9,9a-tetrahydro-5,8a-dimethyl-3-methylene-, (3aR-(3aalpha,8abeta,9aalpha))-
Click to Show/Hide
|
||||
Species Origin | princeps ... | Click to Show/Hide | |||
princeps | |||||
Disease | Acute myeloid leukemia [ICD-11: 2A60] | Investigative | [1] | ||
Structure |
Click to Download Mol2D MOL |
||||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C15H16O3
|
||||
PubChem CID | |||||
Canonical SMILES |
CC1=C2CC3C(CC2(C=CC1=O)C)OC(=O)C3=C
|
||||
InChI |
1S/C15H16O3/c1-8-10-6-11-9(2)12(16)4-5-15(11,3)7-13(10)18-14(8)17/h4-5,10,13H,1,6-7H2,2-3H3/t10-,13-,15-/m1/s1
|
||||
InChIKey |
ONPJVBQNWRHOKG-WDBKCZKBSA-N
|
||||
CAS Number |
CAS 10067-18-2
|
||||
Herb ID | |||||
SymMap ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
1,25-dihydroxyvitamin D3 | Congenital alopecia | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) | Combination Info click to show the detail info of this combination | |||||
In-vitro Model | HL-60 | CVCL_0002 | Adult acute myeloid leukemia | Homo sapiens | ||
Experimental
Result(s) |
Yomogin may be useful in combination with 1,25-(OH)(2) D(3) or all- trans-RA in the differentiation therapy for myeloid leukemias. |